DNA–SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly desmoplastic cancer with limited treatment options. There is an urgent need for tools that monitor therapeutic responses in real time. Drugs such as gemcitabine and irinotecan elicit their therapeutic effect in cancer cells by producing hydrogen pe...
Main Authors: | Gong, Xun, Son, Manki, Nguyen, Freddy T., Strano, Michael S. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research (AACR)
2020
|
Online Access: | https://hdl.handle.net/1721.1/125234 |
Similar Items
-
The T cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019) -
PKM2 is not required for pancreatic ductal adenocarcinoma
by: Danai, Laura V, et al.
Published: (2018) -
Identifying genes that are required for the maintenance of pancreatic ductal adenocarcinoma
by: Jenq, Harry
Published: (2013) -
The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
by: Wang, L, et al.
Published: (2015) -
Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
by: Lau, Allison N, et al.
Published: (2021)